Back to search
Center-involved Diabetic Macular Edema (CI-DME)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Center-involved Diabetic Macular Edema (CI-DME) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Center-involved Diabetic Macular Edema (CI-DME) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in the back part of the eye (call…
Phase 2 open label, randomized, active controlled, dose-ranging trial in adults with Center Involved - Diabetic Macular Edema (CI - DME)
ABBV-RGX-314 is being developed as a novel, potential one-time gene therapy treatment for the treatment of Diabetic Retinopathy (DR) with and without Center-Inv…
Both aflibercept and bevacizumab have been shown to improve vision in eyes with DME. In eyes with DME and at least moderate vision loss, both aflibercept and be…